0 XP   0   0   0

Item 9 Labs Corp
Buy, Hold or Sell?

I guess you are interested in Item 9 Labs Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Item 9 Labs Corp

Let's start. I'm going to help you getting a better view of Item 9 Labs Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Item 9 Labs Corp even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Item 9 Labs Corp is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Item 9 Labs Corp. The closing price on 2022-10-03 was $0.3875 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Item 9 Labs Corp Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Item 9 Labs Corp.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Item 9 Labs Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Item 9 Labs Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -110.9% means that $[indicator name=netProfitMargin&period=MRQ&percentage=1 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Item 9 Labs Corp:

  • The MRQ is -110.9%. The company is making a huge loss. -2
  • The TTM is -92.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-110.9%TTM-92.9%-18.0%
TTM-92.9%YOY-82.6%-10.4%
TTM-92.9%5Y-115.7%+22.7%
5Y-115.7%10Y-1,810.8%+1,695.2%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-110.9%-0.9%-110.0%
TTM-92.9%0.3%-93.2%
YOY-82.6%0.1%-82.7%
5Y-115.7%-0.9%-114.8%
10Y-1,810.8%-0.3%-1,810.5%
1.1.2. Return on Assets

Shows how efficient Item 9 Labs Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Item 9 Labs Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • -4.5% Return on Assets means that Item 9 Labs Corp generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Item 9 Labs Corp:

  • The MRQ is -4.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.5%TTM-4.6%+0.0%
TTM-4.6%YOY-9.8%+5.2%
TTM-4.6%5Y-10.5%+5.9%
5Y-10.5%10Y-157.6%+147.1%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.5%0.1%-4.6%
TTM-4.6%0.1%-4.7%
YOY-9.8%-0.1%-9.7%
5Y-10.5%-0.2%-10.3%
10Y-157.6%-0.1%-157.5%
1.1.3. Return on Equity

Shows how efficient Item 9 Labs Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Item 9 Labs Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • -7.0% Return on Equity means Item 9 Labs Corp generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Item 9 Labs Corp:

  • The MRQ is -7.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.0%TTM-6.5%-0.4%
TTM-6.5%YOY-24.4%+17.9%
TTM-6.5%5Y-21.3%+14.7%
5Y-21.3%10Y-11.0%-10.3%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.0%0.6%-7.6%
TTM-6.5%0.4%-6.9%
YOY-24.4%0.4%-24.8%
5Y-21.3%-0.3%-21.0%
10Y-11.0%0.1%-11.1%

1.2. Operating Efficiency of Item 9 Labs Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Item 9 Labs Corp is operating .

  • Measures how much profit Item 9 Labs Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Item 9 Labs Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of -78.0% means the company generated $-0.78  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Item 9 Labs Corp:

  • The MRQ is -78.0%. The company is operating very inefficient. -2
  • The TTM is -61.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-78.0%TTM-61.2%-16.9%
TTM-61.2%YOY-39.0%-22.1%
TTM-61.2%5Y-81.6%+20.4%
5Y-81.6%10Y-298.6%+217.1%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-78.0%2.5%-80.5%
TTM-61.2%1.6%-62.8%
YOY-39.0%2.7%-41.7%
5Y-81.6%2.0%-83.6%
10Y-298.6%1.3%-299.9%
1.2.2. Operating Ratio

Measures how efficient Item 9 Labs Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 2.46 means that the operating costs are $2.46 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Item 9 Labs Corp:

  • The MRQ is 2.458. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.978. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.458TTM1.978+0.480
TTM1.978YOY1.445+0.532
TTM1.9785Y2.026-0.048
5Y2.02610Y7.488-5.463
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4581.497+0.961
TTM1.9781.446+0.532
YOY1.4451.389+0.056
5Y2.0261.370+0.656
10Y7.4881.182+6.306

1.3. Liquidity of Item 9 Labs Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Item 9 Labs Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 0.14 means the company has $0.14 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Item 9 Labs Corp:

  • The MRQ is 0.144. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.394. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.144TTM0.394-0.250
TTM0.394YOY0.805-0.411
TTM0.3945Y0.983-0.588
5Y0.98310Y0.512+0.471
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1441.902-1.758
TTM0.3941.908-1.514
YOY0.8052.112-1.307
5Y0.9832.173-1.190
10Y0.5121.891-1.379
1.3.2. Quick Ratio

Measures if Item 9 Labs Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean)
  • A Quick Ratio of 0.01 means the company can pay off $0.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Item 9 Labs Corp:

  • The MRQ is 0.015. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.065. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.015TTM0.065-0.050
TTM0.065YOY0.280-0.215
TTM0.0655Y0.236-0.171
5Y0.23610Y0.122+0.114
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0150.667-0.652
TTM0.0650.792-0.727
YOY0.2800.819-0.539
5Y0.2360.838-0.602
10Y0.1220.823-0.701

1.4. Solvency of Item 9 Labs Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Item 9 Labs Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 0.35 means that Item 9 Labs Corp assets are financed with 34.9% credit (debt) and the remaining percentage (100% - 34.9%) is financed by its owners/shareholders. -110.9%

Let's take a look of the Debt to Asset Ratio trends of Item 9 Labs Corp:

  • The MRQ is 0.349. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.301. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.349TTM0.301+0.047
TTM0.301YOY0.324-0.023
TTM0.3015Y0.377-0.075
5Y0.37710Y11.375-10.999
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3490.433-0.084
TTM0.3010.425-0.124
YOY0.3240.396-0.072
5Y0.3770.402-0.025
10Y11.3750.404+10.971
1.4.2. Debt to Equity Ratio

Measures if Item 9 Labs Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Equity ratio of 53.5% means that company has $0.54 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Item 9 Labs Corp:

  • The MRQ is 0.535. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.435. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.535TTM0.435+0.101
TTM0.435YOY0.690-0.256
TTM0.4355Y0.720-0.285
5Y0.72010Y0.372+0.348
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5350.668-0.133
TTM0.4350.677-0.242
YOY0.6900.624+0.066
5Y0.7200.686+0.034
10Y0.3720.705-0.333

2. Market Valuation of Item 9 Labs Corp

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Item 9 Labs Corp.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -3.51 means the investor is paying $-3.51 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Item 9 Labs Corp:

  • The EOD is -1.701. Company is losing money. -2
  • The MRQ is -3.511. Company is losing money. -2
  • The TTM is -8.067. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-1.701MRQ-3.511+1.810
MRQ-3.511TTM-8.067+4.556
TTM-8.067YOY-14.812+6.745
TTM-8.0675Y-10.911+2.844
5Y-10.91110Y-5.677-5.234
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-1.701-0.010-1.691
MRQ-3.511-0.067-3.444
TTM-8.067-0.006-8.061
YOY-14.812-0.031-14.781
5Y-10.9113.518-14.429
10Y-5.6774.263-9.940
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Item 9 Labs Corp.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Item 9 Labs Corp:

  • The MRQ is -0.070. Very Bad. -2
  • The TTM is -0.151. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-0.070TTM-0.151+0.081
TTM-0.151YOY1.614-1.765
TTM-0.1515Y0.378-0.529
5Y0.37810Y0.209+0.169
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0700.003-0.073
TTM-0.1510.019-0.170
YOY1.6140.024+1.590
5Y0.3780.023+0.355
10Y0.2090.026+0.183

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Item 9 Labs Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 0.98 means the investor is paying $0.98 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Item 9 Labs Corp:

  • The EOD is 0.475. Very good. +2
  • The MRQ is 0.981. Very good. +2
  • The TTM is 1.386. Good. +1
Trends
Current periodCompared to+/- 
EOD0.475MRQ0.981-0.506
MRQ0.981TTM1.386-0.405
TTM1.386YOY6.302-4.916
TTM1.3865Y3.266-1.880
5Y3.26610Y1.686+1.581
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD0.4751.407-0.932
MRQ0.9811.588-0.607
TTM1.3862.019-0.633
YOY6.3022.258+4.044
5Y3.2661.986+1.280
10Y1.6861.531+0.155

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Item 9 Labs Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.8160.869-6%0.828-1%0.452+80%0.233+249%
Book Value Per Share Growth---0.047-0.164+249%0.323-115%0.074-163%0.074-163%
Current Ratio--0.1440.394-63%0.805-82%0.983-85%0.512-72%
Debt To Asset Ratio--0.3490.301+16%0.324+7%0.377-7%11.375-97%
Debt To Equity Ratio--0.5350.435+23%0.690-22%0.720-26%0.372+44%
Dividend Per Share----0%-0%-0%-0%
Eps---0.057-0.057+0%-0.038-33%-0.044-22%-0.412+626%
Eps Growth--50.269-3.727+107%6.932+625%-27.287+154%18.247+176%
Gains Per Share---0.047-0.164+249%0.323-115%0.074-163%0.074-163%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.645+55%
Net Profit Margin---1.109-0.929-16%-0.826-26%-1.157+4%-18.108+1532%
Operating Margin---0.780-0.612-22%-0.390-50%-0.816+5%-2.986+283%
Operating Ratio--2.4581.978+24%1.445+70%2.026+21%7.488-67%
Pb Ratio0.475-106%0.9811.386-29%6.302-84%3.266-70%1.686-42%
Pe Ratio-1.701+52%-3.511-8.067+130%-14.812+322%-10.911+211%-5.677+62%
Peg Ratio---0.070-0.151+116%1.614-104%0.378-118%0.209-133%
Price Per Share0.388-106%0.8001.213-34%2.550-69%2.163-63%1.204-34%
Quick Ratio--0.0150.065-77%0.280-95%0.236-94%0.122-88%
Return On Assets---0.045-0.046+1%-0.098+116%-0.105+131%-1.576+3372%
Return On Equity---0.070-0.065-6%-0.244+251%-0.213+205%-0.110+57%
 EOD+2 -1MRQTTM+7 -11YOY+7 -115Y+11 -710Y+13 -6

3.2. Fundamental Score

Let's check the fundamental score of Item 9 Labs Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.701
Price to Book Ratio (EOD)Between0-10.475
Net Profit Margin (MRQ)Greater than0-1.109
Operating Margin (MRQ)Greater than0-0.780
Quick Ratio (MRQ)Greater than10.015
Current Ratio (MRQ)Greater than10.144
Debt to Asset Ratio (MRQ)Less than10.349
Debt to Equity Ratio (MRQ)Less than10.535
Return on Equity (MRQ)Greater than0.15-0.070
Return on Assets (MRQ)Greater than0.05-0.045
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Item 9 Labs Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.146
Ma 20Greater thanMa 500.433
Ma 50Greater thanMa 1000.576
Ma 100Greater thanMa 2000.692
OpenGreater thanClose0.400
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets120,528
Total Liabilities42,021
Total Stockholder Equity78,493
 As reported
Total Liabilities 42,021
Total Stockholder Equity+ 78,493
Total Assets = 120,528

Assets

Total Assets120,528
Total Current Assets5,692
Long-term Assets5,692
Total Current Assets
Cash And Cash Equivalents 442
Net Receivables 592
Inventory 4,131
Total Current Assets  (as reported)5,692
Total Current Assets  (calculated)5,164
+/- 528
Long-term Assets
Property Plant Equipment 27,308
Goodwill 58,233
Intangible Assets 19,223
Other Assets 10,072
Long-term Assets  (as reported)114,836
Long-term Assets  (calculated)114,836
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities39,470
Long-term Liabilities2,551
Total Stockholder Equity78,493
Total Current Liabilities
Short Long Term Debt 27,799
Accounts payable 5,819
Other Current Liabilities 223
Total Current Liabilities  (as reported)39,470
Total Current Liabilities  (calculated)33,841
+/- 5,629
Long-term Liabilities
Long term Debt 1,449
Capital Lease Obligations Min Short Term Debt1,013
Other Liabilities 346
Long-term Liabilities  (as reported)2,551
Long-term Liabilities  (calculated)2,808
+/- 256
Total Stockholder Equity
Common Stock11
Total Stockholder Equity (as reported)78,493
Total Stockholder Equity (calculated)11
+/- 78,482
Other
Capital Stock11
Common Stock Shares Outstanding 96,263
Net Debt 28,806
Net Invested Capital 107,740
Net Tangible Assets 1,037
Net Working Capital -33,778



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-06-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-30
> Total Assets 
20
20
0
900
451
1,139
637
765
595
442
538
509
495
509
630
471
421
113
77
103
47
5,044
0
17,137
19,384
14,474
14,644
21,490
22,309
20,664
25,983
153,134
149,923
116,809
117,021
120,874
120,528
120,528120,874117,021116,809149,923153,13425,98320,66422,30921,49014,64414,47419,38417,13705,04447103771134214716305094955095384425957656371,13945190002020
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
96
63
91
38
3,261
0
5,341
3,641
2,963
3,011
3,503
4,495
2,892
7,129
14,150
11,477
10,597
8,387
6,884
5,692
5,6926,8848,38710,59711,47714,1507,1292,8924,4953,5033,0112,9633,6415,34103,2613891639600000000000000000
       Cash And Cash Equivalents 
0
0
0
155
14
1
49
88
29
20
97
80
78
43
78
49
35
42
27
44
9
1,674
0
2,902
787
21
47
304
565
85
1,614
4,308
297
1,454
161
105
442
4421051611,4542974,3081,6148556530447217872,90201,67494427423549784378809720298849114155000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
961
0
1,207
396
437
367
563
606
353
1,455
2,566
2,056
1,448
1,623
1,177
592
5921,1771,6231,4482,0562,5661,4553536065633674373961,2070961011100000000000000000
       Inventory 
0
0
0
0
22
12
44
113
60
51
55
48
50
72
69
66
66
45
33
45
26
0
0
0
0
0
0
0
0
0
0
0
0
6,391
5,253
4,820
4,131
4,1314,8205,2536,391000000000000264533456666697250485551601134412220000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,743
11,511
11,633
17,987
17,814
17,771
18,855
138,984
138,446
106,212
81
113,990
114,836
114,836113,99081106,212138,446138,98418,85517,77117,81417,98711,63311,51115,743000000000000000000000000
       Property Plant Equipment 
0
0
0
119
47
25
55
50
45
32
25
18
12
20
30
23
17
14
12
9
7
1,234
0
2,104
5,992
7,170
7,424
7,383
7,364
7,406
7,727
7,978
9,414
11,035
19,206
24,010
27,308
27,30824,01019,20611,0359,4147,9787,7277,4067,3647,3837,4247,1705,9922,10401,23479121417233020121825324550552547119000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,990
5,650
1,116
1,116
1,116
1,116
1,116
1,116
1,116
1,116
58,065
58,065
58,233
58,233
58,23358,23358,06558,0651,1161,1161,1161,1161,1161,1161,1161,1165,6505,99000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
0
100
100
100
100
100
100
0
80
80
80
0
0
0
0
000080808001001001001001001000100000000000000000000000
       Intangible Assets 
0
0
0
343
334
326
317
308
300
291
283
274
265
293
282
271
260
0
0
0
0
0
0
2,928
3,113
1,840
1,738
8,163
8,019
7,765
7,655
128,883
126,923
18,659
18,291
19,590
19,223
19,22319,59018,29118,659126,923128,8837,6557,7658,0198,1631,7381,8403,1132,928000000260271282293265274283291300308317326334343000
       Other Assets 
0
0
0
609
336
358
350
341
332
293
285
279
267
295
284
274
262
2
2
2
2
449
0
674
888
1,285
1,255
1,225
1,215
1,484
2,176
838
836
18,454
12,917
11,426
10,072
10,07211,42612,91718,4548368382,1761,4841,2151,2251,2551,28588867404492222262274284295267279285293332341350358336609000
> Total Liabilities 
56
69
5
2,981
2,997
3,424
3,022
3,258
3,353
3,380
4,289
2,529
2,804
3,145
3,569
4,031
4,570
5,097
5,119
5,147
5,313
2,481
0
2,658
5,372
7,138
9,075
10,398
11,350
12,649
12,783
14,976
14,313
30,708
32,559
38,109
42,021
42,02138,10932,55930,70814,31314,97612,78312,64911,35010,3989,0757,1385,3722,65802,4815,3135,1475,1195,0974,5704,0313,5693,1452,8042,5294,2893,3803,3533,2583,0223,4242,9972,98156956
   > Total Current Liabilities 
56
69
5
2,442
2,833
3,271
2,968
3,209
3,304
1,982
2,064
1,864
1,792
3,097
3,521
4,006
4,557
1,891
1,913
1,921
2,056
981
0
1,158
2,672
7,138
8,900
10,223
8,466
10,289
10,389
12,130
10,560
14,990
15,739
35,599
39,470
39,47035,59915,73914,99010,56012,13010,38910,2898,46610,2238,9007,1382,6721,15809812,0561,9211,9131,8914,5574,0063,5213,0971,7921,8642,0641,9823,3043,2092,9683,2712,8332,44256956
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68
56
44
32
0
0
0
20
4,772
5,241
0
0
0
4,444
3,336
2,157
0
5,510
23,953
0
023,9535,51002,1573,3364,4440005,2414,772200003244566800000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68
56
44
32
0
0
0
20
4,772
5,241
5,056
2,905
5,463
4,444
3,336
2,157
5,813
5,510
23,953
27,799
27,79923,9535,5105,8132,1573,3364,4445,4632,9055,0565,2414,772200003244566800000000000000000
       Accounts payable 
34
47
5
1,212
1,370
1,535
1,496
1,540
1,551
1,868
1,891
1,639
1,655
1,640
1,676
1,674
1,668
1,640
1,680
1,678
1,729
726
0
178
824
1,017
1,253
2,104
2,255
1,977
5,885
8,734
7,657
3,760
9,853
11,207
5,819
5,81911,2079,8533,7607,6578,7345,8851,9772,2552,1041,2531,01782417807261,7291,6781,6801,6401,6681,6741,6761,6401,6551,6391,8911,8681,5511,5401,4961,5351,3701,21254734
       Other Current Liabilities 
0
0
0
224
223
474
227
298
296
38
96
155
78
105
113
158
202
20
172
194
290
89
0
863
910
179
107
107
157
0
60
60
746
120
376
440
223
2234403761207466060015710710717991086308929019417220202158113105781559638296298227474223224000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,700
0
175
175
2,883
2,360
2,394
2,846
3,754
15,718
16,820
2,509
2,551
2,5512,50916,82015,7183,7542,8462,3942,3602,88317517502,700000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,270
2,733
3,653
0
16,265
1,645
0
01,64516,26503,6532,7332,270000000000000000000000000000000
       Other Liabilities 
0
0
0
14
11
0
1
1
1
1,099
1,806
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
656
451
346
346
34634645165600000000000000000000001,8061,09911101114000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
109
451
346
0
0346451109000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,985
-5,042
-5,045
-5,265
2,562
2,562
14,539
14,065
7,460
5,717
11,091
10,960
8,015
13,200
138,158
135,610
86,101
84,462
82,744
78,493
78,49382,74484,46286,101135,610138,15813,2008,01510,96011,0915,7177,46014,06514,5392,5622,562-5,265-5,045-5,042-4,98500000000000000000
   Common Stock
0
0
1
4
4
3
3
3
4
4
3
6
6
6
6
6
7
7
7
8
8
5
0
6
6
6
6
7
7
7
8
10
10
11
11
11
11
1111111110108777666605887776666634433344100
   Retained Earnings Total Equity0-41,097-37,2190-24,828-23,994-24,043000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,685
175,592
173,877
0
135,121
137,280
0
0137,280135,1210173,877175,59250,685000000000000000000000000000000
   Treasury Stock0-13,450-13,4500-13,450-13,450-13,450000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-09-30)

Gross Profit (+$)
totalRevenue21,937
Cost of Revenue-13,324
Gross Profit8,6138,613
 
Operating Income (+$)
Gross Profit8,613
Operating Expense-27,538
Operating Income-5,601-18,926
 
Operating Expense (+$)
Research Development-
Selling General Administrative11,062
Selling And Marketing Expenses-
Operating Expense27,53811,062
 
Net Interest Income (+$)
Interest Income-
Interest Expense-5,295
Net Interest Income-5,295-5,295
 
Pretax Income (+$)
Operating Income-5,601
Net Interest Income-5,295
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-10,906-5,592
EBIT - interestExpense = -10,897
-10,906
-5,610
Interest Expense5,295
Earnings Before Interest and Taxes (ebit)-5,601-5,610
Earnings Before Interest and Taxes (ebitda)-4,350
 
After tax Income (+$)
Income Before Tax-10,906
Tax Provision-0
Net Income From Continuing Ops-10,906-10,906
Net Income-10,906
Net Income Applicable To Common Shares-10,906
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses1,829
Total Other Income/Expenses Net-95,295
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
CTW.BK
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CTW.BK.

CTW.BK Daily Candlestick Chart
C76.SG
35 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of C76.SG.

C76.SG Daily Candlestick Chart
CSM.VN
53 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CSM.VN.

CSM.VN Daily Candlestick Chart
VND.VN
55 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VND.VN.

VND.VN Daily Candlestick Chart
VNG.VN
55 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VNG.VN.

VNG.VN Daily Candlestick Chart
VCI.VN
55 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VCI.VN.

VCI.VN Daily Candlestick Chart
TPB.VN
55 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TPB.VN.

TPB.VN Daily Candlestick Chart
ST8.VN
55 minutes ago

I found you a Death Cross on the daily chart of ST8.VN.

ST8.VN Daily Candlestick Chart
STB.VN
55 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STB.VN.

STB.VN Daily Candlestick Chart
SJF.VN
55 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SJF.VN.

SJF.VN Daily Candlestick Chart
SBT.VN
55 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SBT.VN.

SBT.VN Daily Candlestick Chart
VIX.VN
55 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VIX.VN.

VIX.VN Daily Candlestick Chart
POW.VN
57 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of POW.VN.

POW.VN Daily Candlestick Chart
NVL.VN
57 minutes ago

I found you a Golden Cross on the daily chart of NVL.VN.

NVL.VN Daily Candlestick Chart
NTL.VN
57 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NTL.VN.

NTL.VN Daily Candlestick Chart
NKG.VN
57 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NKG.VN.

NKG.VN Daily Candlestick Chart
MWG.VN
57 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MWG.VN.

MWG.VN Daily Candlestick Chart
LDG.VN
59 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LDG.VN.

LDG.VN Daily Candlestick Chart
LCG.VN
59 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LCG.VN.

LCG.VN Daily Candlestick Chart
HUB.VN
59 minutes ago

I found you a Falling Three Methods Candle Pattern on the daily chart of HUB.VN.

HUB.VN Daily Candlestick Chart
HT1.VN
59 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HT1.VN.

HT1.VN Daily Candlestick Chart
HMC.VN
59 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HMC.VN.

HMC.VN Daily Candlestick Chart
HCD.VN
59 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HCD.VN.

HCD.VN Daily Candlestick Chart
GEX.VN
59 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GEX.VN.

GEX.VN Daily Candlestick Chart
FCM.VN
59 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of FCM.VN.

FCM.VN Daily Candlestick Chart